No. You need to read my post. There is indeed a discount to market for LPC.
This is for completion of the previous $50 million purchase agreement. They are getting close to exceeding the authorized ~7 million shares and want authorization to sell even more until they reach the originally authorized $50 million dollar dilution.
I don't believe dilution in small cap bios with zero revenue works that way. I hope it does...but, I assume the market will discount the SP. And when it creeps up...more dilution will take place because $50,000,000 isn't enough.
We will be starting phase2/3 with only partial funding. As I have stated before. The good dr. meant he had enough cash for the next two years to run current operations. That statement had nothing to do with trials.
Market Data 
Markets 
